Concepedia

Shen Li

SL

Statistics

Publications

12

Citations

389

H-Index

12

Active since

2006

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Broad Institute

Tianjin Medical University

Tianjin Anding Hospital

Shen Li is an author at Harvard University specializing in medicine, pharmacology, and oncology.

ORCID

Publications per year

2006–2025

12

Publications

12

Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist

Derek J. Erstad, Christian T. Farrar, Sarani Ghoshal et al. · Hepatology Communications · 2018 · 60 citations · Full text

, , +16

Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI

Derek J. Erstad, Mozhdeh Sojoodi, Martin S. Taylor et al. · Clinical Cancer Research · 2020 · 60 citations · Full text

, , +17

Distinct Domains for Anti- and Pro-apoptotic Activities of IEX-1

Shen Li, Jinjin Guo, Cynthia Santos‐Berríos et al. · Journal of Biological Chemistry · 2006 · 53 citations · Full text

, , +17

Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis

Shen Li, Sarani Ghoshal, Mozhdeh Sojoodi et al. · Journal of Gastrointestinal Surgery · 2018 · 45 citations · Full text

, , +17

A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery

Émilie Crouchet, Simonetta Bandiera, Naoto Fujiwara et al. · Nature Communications · 2021 · 41 citations · Full text

, , +17

1–5 of 12